Trials darmkanker

Hieronder een overzicht van alle trials op het gebied van darmkanker waar het IKNL trialbureau aan meewerkt. Tijdens de COVID-19-pandemie zijn er verschillende studies tijdelijk gesloten voor inclusie. Inmiddels zijn alle studies in onderstaand overzicht weer geopend voor inclusie. 

  • C2012-5697 CAIRO4  - OPEN - The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer 
  • DCCG 14-01, CAIRO5 - OPEN - Treatment strategies in CRC patients with initially unresectable liver-only metastases 
  • C2015-7715 VU, TESAR - OPEN - Rectal preserving treatment for early rectal cancer. A multicentered randomised trial of radical surgery vs adjuvant chemoradiotherapy after local excision for early rectal cancer. 
  • C2015-8063 VU, COLOR III  - OPEN - TaTME vs LapTME for mid and low rectal cancer 
  • C2016-10795 CZE, CAIRO6 - OPEN - Perioperative systemic therapy and cytoreductive surgery with HIPEC vs upfront cytoreductive surgery with HIPEC alone 
  • C2016-10690 MAX PREHAB - OPEN - Multimodal prehabilitation in CRC patient to improve functional capacity and reduce postoperative complications 
  • C2018-11543, COLOPEC2 - OPEN - Second and third look laparoscopy in pT4 colon cancer patient for ealy detection of peritoneal metastases 
  • C2016-10845 EMCR, FUTURE-mets - OPEN - Follow up after surgery for colorectal liver metastasis 
  • CONNECTION II - OPEN - Improving clinical management of colon cancer through CONNECTION, a nation-wide Colon Cancer Registry and Stratification effort